Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2026-01-13 @ 9:27 AM
Study NCT ID:
NCT06547528
Status:
RECRUITING
Last Update Posted:
2025-06-03
First Post:
2024-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
Sponsor:
Ono Pharmaceutical Co. Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-01
First Submit QC Date:
None
Study First Post Date:
2024-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-01
Last Update Post Date:
2025-06-03
Last Update Post Date Type:
ACTUAL